Menu
NYStateCareers
  • Home
  • Search
    • All New York Jobs
    • Top New York Cities
    • Top Job Searches
  • News
  • Nominate
  • Post
    • Membership
    • Post Jobs
Close Menu

Elekta leads radiation therapy industry through innovation

New York City, Press Releases

ATLANTA, US, September 23 – Elekta’s strategy to be number one in the radiation therapy industry is built on developing advanced products, software and services, which will continue to drive strong growth, according to President and CEO, Tomas Puusepp. He spoke today at the Elekta Capital Markets Day in Atlanta, Georgia during the 55th Annual Meeting of the American Society for Radiation Oncology (ASTRO).

“Elekta’s 40-year history is built upon innovation,” he told the audience of analysts and investors. “And we continue to create history every day by inventing new, revolutionary products and solutions that effectively treat cancer and improve the lives of patients.” He said that Elekta is investing more in research and development than ever before, to improve patient care around the world.

Members of Elekta’s executive management presented several novel products and solutions at the Capital Markets Day, including Versa HD™, Elekta’s new flagship linear accelerator (linac). Dee Mathieson, Senior Vice President, Oncology Business Line Management explained how sales of Versa HD, which allows an unprecedented combination of High Dose Rate delivery and rapid MLC leaf speed, have exceeded expectations. It has been shipped to 13 countries since its launch in March. She also introduced Elekta’s new X-ray Volume Imaging (XVI) system that enables real-time X-ray monitoring of internal motion during radiotherapy delivery.

John Lapré, Executive Vice President, Elekta Brachytherapy said the launch of Esteya®, an elegant new approach to high-precision skin cancer treatment using electronic brachytherapy, was further proof of Elekta’s commitment to innovation. Other examples included development of the MR linac project, a solution that combines radiotherapy delivery and simultaneous magnetic resonance imaging (MRI); and how Elekta continues to drive the stereotactic radiosurgery (SRS) market with Leksell Gamma Knife®. Todd Powell, Executive Vice President, Elekta Software, presented Monaco 5.0, the latest evolution of treatment planning software.

The Elekta Learning and Innovation Center (LINC) is another proof point of Elekta’s dedication to bringing better treatment to more people. LINC is designed to mirror a cancer center and will be a role model for Elekta’s global education and training program.

Renowned professors confirmed Elekta’s leading role as a pioneer and partner in cancer care. Professor Frederik Wenz, Director of the Department of Radiation Oncology of the University Medical Center Mannheim, Germany spoke about Elekta’s latest treatment possibilities. Dr. Dheerendra Prasad, Professor of Neurosurgery and Radiation Oncology, at Roswell Park Cancer Institute, Buffalo, New York recounted his 20 years experience of treating patients using Leksell Gamma Knife® Perfexion™.

Versa HD™ is not available for sale in all markets. Esteya® and Monaco 5.0 are pending 510(k) clearance.

# # #

The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 15:00 CET on September 23, 2013.

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

SOURCE: Elekta

Related Posts

Press Releases

Dollar General to Hire Up to 50,000 New Employees to Support Operations

Press Releases

Dollar General Announces Approximately $35 Million Investment in Employees, 50,000 New Hires

Press Releases

U.S. Bank announces 20% Premium Pay Program for employees and $30M commitment to support individual and small business recovery

News & Views

  • Dollar General to Hire Up to 50,000 New Employees to Support Operations
  • Dollar General Announces Approximately $35 Million Investment in Employees, 50,000 New Hires
  • U.S. Bank announces 20% Premium Pay Program for employees and $30M commitment to support individual and small business recovery
  • CVS Health to provide bonuses, add benefits and hire 50,000 in response to pandemic
  • Papa John’s to Hire 20,000 New Team Members Immediately
Back To Top
NYStateCareers
Copyright © BusinessMVP.com
All Rights Reserved!